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Introduction
An impaired sirtuin/nicotinamide adenine dinucleotide (NAD) system is linked to development of type 2 diabetes (T2D) [1] [2] [3] . Obesity and associated abnormal glucose and lipid metabolism, major risk factors for development of T2D, are also associated with reduced activity of the sirtuin/NAD system [1] [2] [3] . The specific components of the sirtuin/NAD system involved in diet-induced obesity and the development of glucose intolerance have not been established, but studies using global and tissue-specific knockout mice indicate the importance of the peripheral tissues liver, white adipose tissue (WAT) and muscle [2] .
Previous studies in our lab identified distinct phases in development of glucose intolerance and inflammation in mice consuming a high-fat diet (HFD) in liver, WAT and muscle [4] . The mammalian sirtuins are proposed to be conserved nutritional sensors that operate in a concerted fashion to regulate glucose and lipid homeostasis and inflammatory responses [5] [6] [7] . While research has focused on SIRT1, all seven mammalian sirtuins (SIRT1 -7) are likely to be involved in a molecular network orchestrating the response to glucose and lipids in a range of tissues [6) . Sirtuin regulation of glucose and lipid induced inflammation may be a mechanistic link in the impact of HFD on metabolic health [5] . Studies in our lab have identified postprandial induction of SIRT1 gene transcription in parallel with inflammatory responses, with SIRT1 gene transcription levels negatively associated with TNFα [8] . Sirtuin activity is dependent on the co-factor nicotinamide adenine dinucleotide (NAD). NAD biosynthesis is controlled by a number of enzymes, the dietary intake of tryptophan, niacin and nicotinamide riboside precursors, together with salvage pathways that direct biosynthesis from intermediate molecules [9] .
Sirtuins are activated in response to metabolic stressors such HFD, while NAD biosynthesis is compromised at the same time [5, 10, 11] . This implies the potential for the system to become overwhelmed in response to chronic challenges. This may contribute to the development of metabolic dysfunction. This is supported by studies showing that the sirtuin/NAD system is compromised by HFD, diet-induced obesity and metabolic stress [5, 12, 13] . Conversely, activation of the sirtuin/NAD system has been shown to improve fasting serum insulin and glucose and insulin sensitivity [3, 14] .
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The liver, white adipose tissue (WAT) and muscle are all involved in glucose and lipid homeostasis and sirtuin regulated processes are known to be important in these tissues [2, 15] . Studies in our lab indicated that while HFD can induce marked glucose intolerance within days, increased inflammatory markers in liver, adipose and muscle are initially transitory [4] . However, a second phase of increased glucose intolerance with long-term HFD is associated with marked increased adiposity and increased inflammation [4] . The potential role of the sirtuin/NAD system in the liver,
WAT and muscle tissue in response to HFD in this process is not clear. Thus, the interplay between the seven members of the sirtuin gene family and the genes encoding enzymes that regulate the biosynthetic pathways to generate NAD is investigated in this study with a focus on transcriptional regulation to exploit the potential of this system in developing strategies to restore and maintain metabolic health.
Materials and Methods

Animals
The present study was conducted using tissue from mice used in our previous study [4] . Animal studies were licensed under the Animal (Scientific Procedures) Act of 1986 with approval from the Rowett Institute of Nutrition and Health's Ethical Review Committee. Briefly, male C57BL/6 mice (n=12 per diet group), 12 weeks of age were fed a HFD (60% of energy from fat) or a LFD diet (10% of energy from fat) (D12492 and D12450B, respectively, Research Diets, NJ, US) ad libitum. Sirtuin/NAD system components associated with our previous observations of distinct phases of the development of diet induced obesity and glucose intolerance [4] were examined in mice fed diets for A C C E P T E D M A N U S C R I P T [4] . The mice were housed in a 12 h light/12 h dark cycle. All mice were sacrificed within a 3 hour period beginning at 2.5 hours from the start of the 12 hour light cycle.
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mSIRTNADplex assay
Total RNA (liver, WAT, soleus muscle) extraction was described previously [4] . Total RNA (50 ng) was assayed (n=6-8) for sirtuin and NAD biosynthetic enzyme gene expression using our in-house custom designed assay, the mSIRTNADplex. The procedures for design and optimisation of the mSIRTNADplex and the selected gene targets and primer assays are detailed in Supplementary files S1 and S2 respectively.
NAD/NADH assay
NAD and NADH levels were measured using a commercially available fluorimetric assay kit (Abcam, Cambridge, UK) and a Spectra Max Gemini XS fluorimeter (Molecular Diagnostics) (fluorescence excitation 540nm/emission 590nm). NAD and NADH were extracted from tissue lysates (n=5-8)
using the solutions suppled with the kit. NAD and NADH were specifically recognised and detected using an enzyme cycling reaction. Background fluorescence was subtracted from tissue lysate NAD, NADH and total NAD/NADH was then assessed using the standard curves generated with the NAD and NADH standard stock solutions supplied with the kit.
ELISA
Protein homogenates were prepared by bead-grinding ~20mg tissue with PreCellys 24 (Bertin Technologies, UK) in 400ul of phosphate buffer (pH 7.4). Homogenates were centrifuged at 5000 x g and aliquots of supernatants were frozen at -70 C until analysis. Protein concentration was estimated using Bradford Reagent (B6916 Sigma, UK) and serum bovine albumin standards with 
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Plasma hormones and lipids
Plasma hormones, cytokines (insulin, leptin, IL-1β, IL-6, TNFα) and lipids (HDL and LDL cholesterol, triacylglycerol and non-esterified fatty acids) were assessed in the same mice (n=6-8) and reported previously [4] .
Glucose tolerance
Intra-peritoneal glucose tolerance tests (IPGTTs) were performed on a separate group of mice (n=6-8), as reported previously [4] .
Statistical Analysis
Principal Component Analysis (PCA) was performed using SIMCA-P+ 12.0 software (MKS Instruments UK Ltd, Cheshire) on normalised gene expression data. Two-way analysis of variance (ANOVA) was performed on normalised gene expression and protein data with diet and time as factors, using Gen Stat®13th Edition (VSN International, Ltd., Hemel Hempstead, UK). A post-hoc Bonferroni or Tukey's correction for multiple comparisons of time points within an ANOVA was applied (significance level 0.05) to gene expression and protein data respectively. ANOVA was conducted on a log scale if data was skewed. Pearson correlations were calculated using Genstat. Pairwise comparisons of tissue NAD and NADH levels were conducted using Student's ttest (significance level 0.05).
Results
Acute and chronic responses to HFD
A C C E P T E D M A N U S C R I P T Phenotypic data for the mice were reported previously [4] and are summarised here in the Graphical Abstract accompanying this manuscript. Briefly, body weight and adiposity of HFD mice increased significantly after 3 days of HFD and increased linearly with time when compared to LFD mice [4] .
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The acute response within 3 days of HFD and glucose intolerance assessed by intraperitoneal glucose tolerance tests (IPGTT) (50% increase in area under the curve, AUC) was attributed to increased caloric intake and fat content of the diet respectively. Glucose intolerance then improved to 30% after 1 week, remaining steady up to 12 weeks. After 12 weeks a further increase in glucose intolerance (60% AUC) was observed concomitant with WAT and muscle inflammation (chronic response) characterised by increased expression of inflammatory gene markers (see summary Graphical Abstract).
Transcriptional responses of SIRT/NAD system to HFD in liver, WAT and muscle
The mSIRTNADplex gene expression profiles were assayed in liver, WAT and muscle from mice fed a Figure 2D ) and liver respectively ( Figure 2B ). Robust up-regulation in response to HFD was also observed for NMNAT2 (p<0.003) in WAT at 7 days of HFD ( Figure 2C ) and NMRK2 (p<0.001) at 1 week and CD38 (p<0.001) at 16 weeks in muscle ( Figure 2D ). In theory it would be expected that significantly altered gene expression between LFD and HFD mice should be the same in the 7 day (acute phase experiment) and 1week (chronic phase experiment) groups. However, while this is not always the case it was noted that differences in gene expression are indeed similar, but fail to reach significance. This is readily explained by reduced statistical power for some genes and the use of Bonferroni adjusted p-values making the requirement for significance more stringent, unavoidably pushing up type II error rates.
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Correlated SIRT/NAD gene expression
Several mSIRTNADplex genes exhibited correlated regulation with tissue type or HFD (Supplementary File S7 Table S2 ). SIRT4, SIRT7 and NAPRT1 gene expression is highly positively correlated in the liver ( Figures 3A, 3B, 3C ). In muscle NMRK2 and CD38 are significantly positively correlated ( Figure 3D ). Notably, co-regulated SIRT/NAD gene expression was often dependent on consumption of LFD or HFD. Positively correlated gene expression of NMNAT3 with SIRT 4, SIRT7, NAPRT1 and NNMT in liver was lost when mice were fed HFD (Table 1) . Conversely, TDO2 positively correlated gene expression with SIRT7, NAPRT1, SIRT 4 and ABCA1 in liver was only apparent when mice were fed HFD (Table 1 ). NMNAT3 and TDO2 were negatively correlated in liver only when mice were fed HFD (Table 1) . ABCA1 also exhibited aberrant regulation with diet, being negatively correlated with NMNAT3 and positively correlated NAPRT1 only when fed HFD. Negatively correlated gene expression of ABCA1 and SIRT7 was only observed in liver of LFD mice (Table 1) .
Tissue specific SIRT/NAD gene regulation correlates with metabolic markers and HFD
The genes exhibiting highly significantly altered expression in the liver, WAT and muscle in response to HFD demonstrate significant correlations with a number of metabolic markers (Supplementary File S8 Table S3 ). Correlation analysis demonstrates the reasons why PPIB, initially selected as a potential reference gene, proved unsuitable as a reference gene in this study. PPIB expression was negatively correlated with variables such as body weight (-0.43, p<0.001), fat mass (-0.45, p<0.001), Table S3 ).
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However, other SIRT/NAD system genes demonstrate significant correlation with metabolic parameters dependent on dietary fat consumed, providing further evidence of deregulation of the SIRT/NAD system in response to HFD (Table 2) Table 2 ). NMNAT2 in WAT was positively correlated with insulin when mice were fed a HFD (LFD -0.06, p=0.802, HFD 0.51, p=0.038) ( Table 2 ). NMRK2 expression in muscle was significantly (Table 2) .
Tissue NAD/NADH levels altered with HFD
No significant changes in either total NAD+NADH, or NAD:NADH ratios were observed in comparisons of liver (n=5-8) from LFD or HFD mice at 3 days, 1 week or 16 weeks (data not shown).
No significant changes in either total NAD+NADH were observed in comparisons of WAT from mice fed LFD or HFD at 3 days ( Figure 4A ), but HFD mice at 7 days had significantly increased total NAD+NADH (p=0.002) levels, a consequence of increased NAD (p=0.008) ( Figure 4B ). The NAD:NADH ratio was also significantly higher in WAT (n=5-8) from HFD mice at 3 (p=0.017) and 7 days (p=0.004) ( Figure 4C ). No significant changes in total NAD+NADH, or NAD:NADH ratios were observed in comparisons of muscle (n=3-6) from LFD or HFD mice at 1 week ( Figure 4D ). However, at 8 (p=0.069) ( Figure 4E ) and 16 weeks (p=0.0056) ( Figure 4F ) HFD mice had a reduction in total NAD+NADH. This indicated a reduction in NADH levels that was significant at 16 weeks (p=0.0096) ( Figure 4F ). An increased, but non-significant NAD:NADH ratio was also observed in muscle at 1 (p=0.08), 8 (p=0.16) and 16 (p=0.14) weeks of HFD ( Figure 4G ).
SIRT/NAD system transcriptional responses and development of glucose intolerance and inflammation
IPGTT revealed two phases in development of glucose intolerance in C57Bl/6 mice consuming a HFD [4] (and summarised Graphical Abstract). The first phase occurred within 3 days and was associated with an acute phase response [4] (Graphical Abstract). This was followed by an improvement in glucose tolerance then a stable period with no significant difference between total AUC at the 
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SIRT4 and NMNAT3 protein levels in liver
Transcriptional regulation of the SIRT/NAD system to consumption of HFD appears to be more responsive in the liver compared to WAT or muscle. Consequently, the levels of two significantly altered transcripts, SIRT4 and NMNAT3 were assessed in liver. Similarly to gene transcription the levels of SIRT4 were reduced significantly over time in the acute experiment (p=0.039) ( Figure 5A ).
Whereas a significant time.diet interaction (p=0.015) ( Figure 5A ) was observed in the chronic
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experiment. This was largely attributed to an increased level of SIRT4 at 16 weeks in HFD mice ( Figure 5A ). In contrast to gene expression NMNAT3 protein levels were significantly decreased in response to HFD in the acute experiment (p=012) ( Figure 5B), while there was a trend to decreased NMNAT3 levels at 1 and 8 weeks with levels being equal by 16 weeks (Figure 5B ).
Discussion
Studies have reported that the sirtuin/nicotinamide adenine dinucleotide (NAD) system is impaired in individuals with type 2 diabetes (T2D) and the associated risk factors, obesity, abnormal glucose and lipid metabolism [1] [2] [3] . The sirtuin/NAD system is complex and regulated at both transcriptional, post-translational and enzyme activity level. This study, focused on transcriptional regulation, set out to identify specific components of the sirtuin/NAD system involved in diet-induced obesity and the development of glucose intolerance using a previously validated mouse model that demonstrated two phases of development of glucose intolerance associated with diet induced obesity in liver, WAT and muscle [4] . Phased responses, with altered sirtuin/NAD gene transcription coincident with the acute and chronic responses to HFD were identified. In liver transcriptional responses of SIRT4, SIRT7
and NAPRT1 are prominent during the acute response, indicating an important role in SIRT/NAD system responses to HFD induced stress in liver. However, there is a lack of concomitant increases in SIRT4 protein levels until 16 weeks of HFD consumption when mice become glucose intolerant. The transcriptional response may be induced in an attempt to maintain SIRT4 levels that appear to initially decrease with consumption of HFD. SIRT4 gene expression is no longer significantly elevated when SIRT4 protein levels are significantly elevated ( Figure 5A ). SIRT4 is a negative regulator of oxidative metabolism linked with suppression of enhanced SIRT1 and SIRT3 oxidative capacity [16, 17] and is elevated in genetically diabetic mouse models [16] . Notably, changes in expression of SIRT4 and SIRT7 in response to HFD are positively correlated with NAPRT1 ( Figure 3) . NAPRT1, an important salvage pathway enzyme catalysing conversion of nicotinic acid to β-nicotinic acid mononucleotide (β-NAMN), can alleviate responses to oxidative stress in liver [18] . Loss of NAPRT1 regulation with prolonged consumption of HFD is potentially important in contributing to the resulting loss of metabolic homeostasis. Penke et al., [19] report increased liver NAD levels in mice consuming high fat diet concomitant with increased NAMPT gene and protein expression. Increased expression of enzymes synthesising NAD, NAMPT (salvage pathway synthesis from nicotinamide), (NAPRT1 (salvage pathway synthesis from nicotinic acid) and TDO2 (de novo synthesis from tryptophan) were apparent in this study, but were not associated with increased NAD levels in liver.
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It is probable in our study that elevation of NAMPT, NAPRT1 and TDO2 contribute to a compensatory response to increased demand for NAD in liver of HFD mice and maintenance of liver NAD:NADH ratios. The study by Penke et al., [19] supports this conclusion. Supplementation with NAD precursors could provide added protection to the liver via this route [19] . Both TDO2 and QPRT, highly expressed in liver compared to WAT and muscle, reflect the capacity of the liver to convert tryptophan to NAD. The positive correlation of NAPRT1 and TDO2 is lost during the development of obesity, perhaps indicating that increased demand for NAD is limited with increased duration of HFD. Indeed the levels of TDO2 and QPRT tend to decrease from 1 -16 weeks of HFD (Supplementary File S4 Figure S2 ). Thus it is likely that NAD/NADH ratios in liver will be adversely affected with continued HFD beyond the 16 week period tested in this study.
The second phase of glucose intolerance in response to HFD, occurring after 12 weeks [4] , is preceded by a second phase of liver sirtuin/NAD system gene regulation. The salvage pathway enzyme, NMNAT3, is significantly elevated after 8 weeks of HFD and remains so for the remainder of the study. NMNAT3 is proposed to be a mitochondrial salvage pathway enzyme [20] generating NAD from β-nicotinic acid mononucleotide (β-NAMN) and β-nicotinamide mononucleotide (β-NMN). This was disputed with failure to detect NMNAT3 in the mitochondrial proteome [21] and speculation surrounding NMNAT3 transcript variants [22] . Transcriptional elevation of NMNAT3 and TDO2 is not associated with increased levels of NAD in liver and is possibly a response to increased NAD demand and a loss of NMNAT3 protein. Increased NMNAT3 transcription may be a response to falling levels of NMNAT3 in liver of HFD mice ( Figure 5B ). The second phase of glucose intolerance is also characterised by significantly down-regulated ABCA1 at 16 weeks of HFD. Hepatic ABCA1 is a ratelimiting enzyme in HDL biogenesis [23] reported to improve B-cell function and glucose tolerance [24] . Notably, ABCA1 down-regulation in liver is preceded by down-regulation in muscle and elevated plasma HDL and LDL cholesterol and triglycerides. These events may mark the prelude to loss of metabolic homeostasis and development of glucose intolerance in the chronic phase.
NNMT, elevated in HFD mice has been linked to development of obesity, diabetes and metabolic syndrome [25] [26] [27] . NNMT expression was not correlated with increasing fat mass in HFD mice, but is elevated when mice consume HFD. Research on NNMT has largely focused on its association with carcinogenesis [28, 29] . Likewise SIRT7 has also been implicated in carcinogenesis [30, 31] . The upregulation of these transcripts in response to HFD may have implications for links between obesity and increased risk of hepatic cancer [32] . More recently NNMT has also been linked to metabolic benefits in liver with it's product N 1 -methylnicotinamide reported to decrease serum and liver cholesterol [33] . However, although marked increases in NNMT expression was consistently observed in mice fed a HFD this did not prevent elevated serum cholesterol, but it is possible that up-regulation of the NNMT gene is an indication of liver responses to attempt to maintain homeostatic control of lipid homeostasis in response to consumption of a HFD.
Transcriptional regulation of the sirtuin/NAD system was less pronounced in WAT compared to liver. This is not surprising as previous analysis indicated gains in adiposity and inflammation are not seen in WAT during the acute response in the liver in response to HFD [4] . However, prolonged HFD resulted in increases in adiposity and inflammation in WAT between 12 and 16 weeks. This is preceded by an elevation of NMNAT2 following 7 days on HFD, associated with increased levels of NAD and NAD:NADH ratios at 3 and 7 days of HFD. NMNAT enzymes generate NAD from the precursors, β-nicotinic acid mononucleotide (β-NAMN) and β-nicotinamide mononucleotide (β- NMN). This may indicate an adaptation to changes in WAT in response to increasing adiposity. There was a strong correlation of NMNAT2 with plasma insulin. Thus despite a lack of major changes in the sirtuin/NAD system in WAT, NMNAT2 transcripts appear to be associated with inflammation in WAT and glucose intolerance.
Previous studies indicated that muscle tissue was not associated with the acute response to HFD [4] .
The second phase of glucose intolerance in HFD mice revealed up-regulation of NMRK2 (1 week) and CD38 (16 weeks) and down-regulation of ABCA1 at 8 weeks. NMRK2 converts nicotinamide riboside to the NAD precursor, β-NMN [34] . NMRK2 expression is markedly higher in muscle compared to liver and WAT. NMRK2 increases NAD and insulin sensitivity [35] . High expression levels and robust responses to HFD provide evidence that NMRK2 is important in regulating NAD in muscle. Elevated NMRK2 is not maintained becoming negatively correlated with increased body weight and fat mass, plasma HDL and basal glucose (see Table 2 ). The onset of increased glucose intolerance between 12 and 16 weeks is coincident with elevated CD38 ( Figure 2D ). CD38, a major NADase in tissues, is necessary for diet-induced obesity linked to sirtuins [36] and is supported by the significant positive correlations of muscle CD38 gene regulation with body weight and fat mass, plasma HDL and leptin (Table S3 ) and accumulation of lipid in muscle [4] . CD38 knockout mice fed a HFD have increased NAD levels, sirtuin activity and reduced fat droplets in muscle [36] . Notably, CD38 is regulated at the transcriptional level by IL6 [37] which is elevated in muscle of HFD mice at 12 and 16 weeks [4] . The reduced levels of NMRK2 with duration of HFD and the up-regulation of CD38 at 16 weeks, may contribute to the observed reduction in total NAD/NADH levels at this time. Analogous to the changes seen in WAT there was a trend towards increased NAD:NADH ratios in muscle in HFD mice.
Christensen et al., [38] propose that increased NAD:NADH ratios are associated with altered energy metabolism and metabolic phenotype indicating reduced glycolysis and increased fatty acid biosynthesis. This may contribute to eventual loss of insulin sensitivity observed with long term high fat feeding. The present study demonstrates a level of complexity in the regulation of the sirtuin/NAD system that has not previously been reported. This study identifies novel tissue specific transcriptional activation of key sirtuin/NAD system components in response to high fat diet, development of obesity and glucose intolerance and potential regulatory factors and transcriptional linkages involved. The regulation of rate-limiting enzymes of NAD biosynthesis appears to be important in the adaptive compensatory response in liver during the acute phase to prevent the negative impact of high fat diet and maintain glucose homeostasis and insulin sensitivity. Indeed, the novel finding of transcriptional activation of NAPRT1 supports previous reports of the importance of this enzyme in maintaining NAD levels in liver [40] . While activation of NMNAT3 implies a compensatory response specifically aimed at maintaining NMNAT3 protein and subsequently NAD pools in mitochondria.
Ultimately, prolonged high fat feeding overwhelms the capacity to maintain homeostatic control concomitant with loss of insulin sensitivity in WAT and muscle. Notably, the activation of NMRK2, an important transcriptionally regulated salvage pathway enzyme in skeletal muscle [39] is not sustained with prolonged high fat feeding. ABCA1 was identified as an important component marking prelude to loss of metabolic homeostasis and development of glucose intolerance. In summary this study has shown that multiple sirtuins that act as control points linked to NAD biosynthetic enzymes regulate metabolic signals, implicating several new sirtuin/NAD molecular targets for targeted intervention to protect against metabolic damage induced by diet-induced obesity.
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Figures
Graphical Abstract Summary of phenotypic data reported previously [4] and associated SIRT/NAD responses to HFD development of obesity and glucose intolerance. Tables   Table 1 Sirtuin/NAD system gene expression in liver correlated with dietary fat.
Table 2
Sirtuin/NAD system genes in liver, WAT and muscle that significantly correlate with dietary fat. 
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